Crohn's Disease — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Adalimumab
Anti-TNF therapy (infliximab or adalimumab) is the treatment of choice for perianal fistulising Crohn's disease that has failed antibiotics. The ACCENT II trial demonstrated fistula healing with infliximab. Azathioprine may be added as combination therapy. Surgical assessment with examination under anaesthesia and seton placement is also important. Mesalazine has no role in perianal Crohn's disease.
Reference: eTG – 2025 – Gastrointestinal; ECCO – 2024 – Crohn's Disease Guidelines